Loading...

LifeMD, Inc.

LFMDNASDAQ
Healthcare
Medical - Pharmaceuticals
$4.57
$-0.07(-1.51%)
U.S. Market opens in 11h 45m

LifeMD, Inc. (LFMD) Stock Overview

Explore LifeMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap218.8M
P/E Ratio-35.58
EPS (TTM)$-0.30
ROE-1.18%
Fundamental Analysis

AI Price Forecasts

1 Month$3.25
3 Months$7.11
1 Year Target$5.95

LFMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LifeMD, Inc. (LFMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.58 and a market capitalization of 218.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.51%
5-Day Change
0.44%
1-Month Change
22.85%
3-Month Change
30.57%
6-Month Change
-25.57%
Year-to-Date (YTD) Change
34.02%
1-Year Change
-25.08%
3-Year Change
172.02%
5-Year Change
-52.20%
All-Time (Max) Change
2185.00%

Contact Information

866 351 5907
236 Fifth Avenue, New York City, NY, 10001

Company Facts

304 Employees
IPO DateJan 29, 2008
CountryUS
Actively Trading

Frequently Asked Questions